CLINICAL_TRIALS
trial_result
· 2026-07-17
Clinical Trial Results: A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma [Phase 3]
Summary
Phase 3 trial results evaluating Lebrikizumab for efficacy and safety in adults with mild to moderate asthma have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2026-07-17